54 results
8-K
EX-99.1
VANI
Vivani Medical Inc
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
Board of Directors. Under Bradbury’s leadership as CEO, Amylin Pharmaceuticals, with partner Alkermes, secured the 2012 approval of Bydureon®
8-K
EX-99.2
VANI
Vivani Medical Inc
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
Executive Leadership Team Co - founder/Co - inventor of Vivani technology PhD Bioengineering (UCSF/UC Berkeley) Management of Technology Certificate … in/Directed 2 IPOs, 2 reverse mergers and 1 SPAC Brigid A. Makes, MBA – Chief Financial Officer Former Executive Director at AstraZeneca with leadership roles
8-K
EX-99.1
VANI
Vivani Medical Inc
6 Mar 24
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
8:30am
the development of its GLP-1 implants for the treatment of obesity and chronic weight management
Under Bradbury’s leadership as CEO, Amylin … Executive Officer. “As a member of Vivani’s distinguished board of directors, Dan’s leadership expertise and deep insight and experience developing
8-K
EX-99.2
VANI
Vivani Medical Inc
28 Feb 24
Regulation FD Disclosure
8:30am
approved by any regulatory authority for an y use. 2
Vivani Executive Leadership Team Co - founder/Co - inventor of Vivani technology PhD … Officer Former Executive Director at AstraZeneca with leadership roles in regulatory affairs, drug development, commercial and business development Former
8-K
EX-99.1
15efap01 jwalvkhg4k1
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
i0y0x32in
18 Sep 23
Regulation FD Disclosure
6:20am
8-K
EX-99.1
b1hmac04ggjf
28 Aug 23
Entry into a Material Definitive Agreement
5:43pm
8-K
EX-99.1
oe36o7
15 May 23
Results of Operations and Financial Condition
6:49am
DEFR14A
o6reall3ldz6y
1 May 23
Revised proxy
4:49pm
8-K
EX-99.1
j0xbp fw0k1we2
14 Nov 22
Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates
4:14pm
8-K
EX-99.1
vb30ck
17 Oct 22
Regulation FD Disclosure
6:45am
8-K
EX-99.1
hvszt4ir98dt
23 Sep 22
Regulation FD Disclosure
6:04am
8-K
EX-99.1
3fdapn
2 Sep 22
Entry into a Material Definitive Agreement
3:42pm
8-K
ggu 2jw1xeuovsy0
2 Sep 22
Entry into a Material Definitive Agreement
3:42pm
425
EX-99.1
2n4eh76ei1ptaql
29 Jul 22
Business combination disclosure
9:07am